SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 3, 2001, Pages 214-220

Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer

(11) Fountzilas, George a Papadimitriou, C b Aravantinos, G c Nicolaides, C f Stathopoulos, G d Bafaloukos, D g Kalofonos, H h Ekonomopoulos, T e Skarlos, D c Pavlidis, N f Dimopoulos, A M b

a ARISTOTLE UNIVERSITY OF THESSALONIKI (Greece)

b ALEXANDRA HOSPITAL (Greece)

c AGII ANARGIRI CANCER HOSPITAL (Greece)

d Ippokration Hospital Thessaloniki (Greece)

e EVANGELISMOS HOSPITAL (Greece)

f UNIVERSITY HOSPITAL OF IOANNINA (Greece)

g METAXA CANCER HOSPITAL (Greece)

h UNIVERSITY OF PATRAS (Greece)

Author keywords

Anthracyclines; Breast cancer; Chemotherapy; Paclitaxel

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TAMOXIFEN; TRIPTORELIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; DOSE RESPONSE; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY REACTION; LEUKOPENIA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PREMENOPAUSE; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; PACLITAXEL; RISK;

EID: 17744389183 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000055321 Document Type: Article

Times cited : (9)

References (16)

1
- 0022921982
- Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer
- (1986) J Clin Oncol , vol.4 , pp. 1162-1170
- Hryniuk, W.¹ Levive, M.N.²

2
- 0002843144
- Experimental evaluation of potential anticancer agents 13. On the criteria and kinetics associated with 'curability' of experimental leukemia
- (1964) Cancer Chemother Rep , vol.35 , pp. 1
- Skipper, H.E.¹ Shabel F.M., Jr.² Wilcox, W.S.³

3
- 0025836890
- Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes
- (1991) J Clin Oncol , vol.9 , pp. 2134-2140
- Buzzoni, R.¹ Bonadonna, G.² Valagussa, P.³ Zambetti, M.⁴

4
- 9244264421
- Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: A Cancer and Leukemia Group B study
- (1996) J Clin Oncol , vol.14 , pp. 1589-1598
- Perloff, M.¹ Norton, L.² Korzun, A.N.³ Wood, W.C.⁴ Carey, R.W.⁵ Gottlieb, A.⁶ Aust, J.C.⁷ Bank, A.⁸ Silver, R.T.⁹ Saleh, F.¹⁰ Canellos, G.P.¹¹ Perry, M.C.¹² Weiss, R.B.¹³ Holland, J.F.¹⁴

5
- 0030841554
- Conceptual basis for advances in the systemic drug therapy of breast cancer
- (1997) Semin Oncol , Issue.SUPPL. 11 , pp. 2-12
- Norton, L.¹

6
- 0031723795
- Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and 10 positive axillary lymph nodes. A feasibility study
- (1998) Oncology , vol.55 , pp. 508-512
- Fountzilas, G.¹ Nikolaides, C.² Aravantinos, G.³ Skarlos, D.⁴ Kosmidis, P.⁵ Papakostas, P.⁶ Stathopoulos, G.P.⁷ Kontostolis, E.⁸ Bafaloukos, D.⁹ Pavlidis, N.¹⁰

7
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Staquet, M.³ Winkler, A.⁴

8
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

9
- 0032927811
- 5-Year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study
- (1999) J Clin Oncol , vol.17 , pp. 1118-1126
- Hudis, C.¹ Fornier, M.² Riccio, L.³ Lebwohl, D.⁴ Crown, J.⁵ Gilweski, T.⁶ Surbone, A.⁷ Currie, V.⁸ Seidman, A.⁹ Reichman, B.¹⁰ Moynahan, M.¹¹ Raptis, G.¹² Sklarin, N.¹³ Theodoulou, M.¹⁴ Weiselberg, L.¹⁵ Salvaggio, R.¹⁶ Panageas, K.S.¹⁷ Yao, T.J.¹⁸ Norton, L.¹⁹

10
- 0032919709
- Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy
- (1999) J Clin Oncol , vol.17 , pp. 93-100
- Hudis, C.¹ Seidman, A.² Baselga, J.³ Raptis, G.⁴ Lebwohl, D.⁵ Gilewski, T.⁶ Moynahan, M.⁷ Sklarin, N.⁸ Fennelly, D.⁹ Crown, J.P.A.¹⁰ Surbone, A.¹¹ Uhlenhopp, M.¹² Riedel, E.¹³ Yao, T.J.¹⁴ Norton, L.¹⁵

11
- 0030913595
- Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclo-phosphamide regimen for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-22
- (1997) J Clin Oncol , vol.15 , pp. 1857-1869
- Fisher, B.¹ Anderson, S.² Wickerham, D.L.³ DeCillis, A.⁴ Dimitrov, N.⁵ Mamounas, E.⁶ Wolmark, N.⁷ Pugh, R.⁸ Atkins, J.N.⁹ Meyers, F.J.¹⁰ Abramson, N.¹¹ Wolter, J.¹² Bornstein, R.S.¹³ Levy, L.¹⁴ Romond, E.H.¹⁵ Caggiago, V.¹⁶ Grimaldi, M.¹⁷ Jochimsen, P.¹⁸ Deckers, P.¹⁹

12
- 0032730426
- Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25
- (1999) J Clin Oncol , vol.17 , pp. 3374-3388
- Fisher, B.¹ Anderson, S.² DeCillis, A.³ Dimitrov, N.⁴ Atkins, J.N.⁵ Febrenbacher, L.⁶ Henry, P.H.⁷ Ramond, E.H.⁸ Lanier, K.S.⁹ Davila, E.¹⁰ Kardinal, C.G.¹¹ Laufman, L.¹² Pierce, H.I.¹³ Abramson, N.¹⁴ Keller, A.M.¹⁵ Hamm, J.T.¹⁶ Wicherham, D.L.¹⁷ Begovic, M.¹⁸ Tan-Chiu, E.¹⁹ Tian, W.²⁰ Wolmark, N.²¹ more..

13
- 84994521433
- Paclitaxel (Taxol)
- (1995) N Engl J Med , vol.332 , pp. 1004-1014
- Rowinsky, E.K.¹ Donehower, R.S.²

14
- 0003150526
- Clinical outcomes of node-positive breast cancer patients treated with dose-intensified Adriamycin/cyclophosphamide (AC) followed by Taxol as adjuvant systemic chemotherapy (CALGB 9141)
- (1997) Proc Am Soc Clin Oncol , vol.16
- Demerdi, G.D.¹ Berry, D.² Norton, L.³ Broadwater, G.⁴ Robert, N.J.⁵ Duggan, D.⁶ Henderson, I.C.⁷

15
- 0001261990
- For CALGB, ECOG, SWOG and NCCTG: Improved disease-free and overall survival from the addition of sequential paclitaxel but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer
- (1998) Proc Am Soc Clin Oncol , vol.17
- Henderson, I.¹ Berry, D.² Demerti, G.³ Cirrincione, C.⁴ Goldstein, L.⁵ Martino, S.⁶ Ingle, J.N.⁷ Cooper, M.R.⁸ Canellos, G.⁹ Borden, E.¹⁰ Fleming, G.¹¹ Holland, J.F.¹² Graziano, S.¹³ Carpenter, J.¹⁴ Muss, H.¹⁵ Norton, L.¹⁶

16
- 5244234232
- Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node positive breast cancer patients
- A Hellenic Cooperative Oncology Group Study
- (1996) Oncology , vol.53 , pp. 137-146
- Fountzilas, G.¹ Polichronis, A.² Katsohis, K.³ Gennatas, K.⁴ Toussis, D.⁵ Skarlos, D.⁶ Kosmidis, P.⁷ Vassilaros, S.⁸ Semoglou, C.⁹ Giannakakis, T.¹⁰ Fahantidis, G.¹¹ Klouvas, G.¹² Potamianou, A.¹³ Tsavaris, N.¹⁴ Konstantaras, C.¹⁵ Makrantonakis, P.¹⁶ Kolotas, C.¹⁷ Hainoglou, D.¹⁸ Mylonakis, N.¹⁹ Pavlidis, N.²⁰ more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.